117 filings
8-K
NRIX
Nurix Therapeutics Inc
17 Jun 24
Regulation FD Disclosure
7:02am
S-3ASR
NRIX
Nurix Therapeutics Inc
11 Jun 24
Automatic shelf registration
4:06pm
8-K
NRIX
Nurix Therapeutics Inc
21 May 24
Submission of Matters to a Vote of Security Holders
7:06am
8-K
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
424B5
eble8o16z6de8 tko
11 Apr 24
Prospectus supplement for primary offering
4:06pm
8-K
c4llhe 5ua54g1el5sz
10 Apr 24
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
7:02am
8-K
gcxjsa
9 Apr 24
Other Events
1:17pm
ARS
sscof osol8b799ondt8
27 Mar 24
Annual report to shareholders
7:03am
DEFA14A
spys706z0
27 Mar 24
Additional proxy soliciting materials
7:02am
8-K
4p9btsb38b3
11 Mar 24
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
7:02am
S-8
j0on98csyrsbipo
15 Feb 24
Registration of securities for employees
4:51pm
8-K
1obn fcv0avnj66
15 Feb 24
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
4:01pm
8-K
wtwjjqb1
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
mb6o ab2lzym81
11 Dec 23
Other Events
12:03pm
8-K
yu904c jda
13 Nov 23
Regulation FD Disclosure
7:01am
8-K
msq8q9y2f4l9jh
1 Nov 23
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
4:02pm